Introducing JLK BIO

JLK BIO is highly committed to make human life healthier and happier through fast and smart drug discovery and development using AI. DeepHits™ is an AI platform of JLK BIO, featured by our unique model called "Universal Encoder" which maps semantic features of chemicals to information-rich representation in “JLK BIO Chemical Space”.

 

Along with our state-of-the-art AI technology, we understand irreplaceable roles of human in decision making; In this regard, we are very proud of our team consisted of experts with wide and deep knowledge and abundant experiences in diverse fields. Everyone in the team has shown the talents and remarkable track records in their own specialties.

JLK BIO aims to find promising new drug candidates through open innovation and DeepHits™. As a member of JLK Group, JLK BIO will keep challenge beyond possibility for the good of all humantiy.

Our Mission

We challenge ourselves to make human life healthier and happier through fast and smart drug discovery and development using artificial intelligence (AI) on top of collaborative open innovation.

 

Our Vision

We aim to be the number one AI driven innovative biotech company standing out among global AI companies in drug discovery and development. As a leading AI biotech company, we are looking forward to being the best partner of scientists by complementing their capacity in developing innovative drug candidates and, therefore, leading to commercial success.

Team Members

Hyun Jun Hwang

Chief Executive Officer

Jeong Dokgo

Chief Development Officer

Sang Ho Lee

Chief Science Adviser

Zi-Ho Yeom

Chief Business Officer

 

Scientific Advisory Board

Nam Ik Cho

Nam Ik Cho

Artificial Intelligence

In Su Kim

In Su Kim

Medicinal Chemistry

Jung Hoon Lee

Jung Hoon Lee

Patent Attorney

Young Kee Shin

Young Kee Shin

Pathology

Gyu Bong Kim

Gyu Bong Kim

Toxicology

Sung Hee Um

Sung Hee Um

Molecular Cell Biology

Tae Moo Yoo

Tae Moo Yoo

Regulatory Affair